Aileron Therapeutics Inc (ALRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
Operating Expenses | 7,379 | 7,313 | 6,982 | 7,498 | 9,659 |
Operating Income | -7,379 | -7,313 | -6,982 | -7,498 | -9,659 |
Other Income | 207 | 100 | -52 | 64 | 168 |
Pre-tax Income | -7,172 | -7,213 | -7,034 | -7,434 | -9,491 |
Net Income Continuous | -7,172 | -7,213 | -7,034 | -7,434 | -9,491 |
Net Income | $-7,172 | $-7,213 | $-7,034 | $-7,434 | $-9,491 |
EPS Basic Total Ops | -5.20 | -9.80 | -9.60 | -10.00 | -12.80 |
EPS Basic Continuous Ops | -5.21 | -9.74 | -9.54 | -10.09 | -12.88 |
EPS Diluted Total Ops | -5.20 | -9.80 | -9.60 | -10.00 | -12.80 |
EPS Diluted Continuous Ops | -5.21 | -9.74 | -9.54 | -10.09 | -12.88 |
EBITDA(a) | $-7,412 | $-7,316 | $-7,002 | $-7,502 | $-9,672 |